SWG1: Sex & Gender Working Group
SWG1: Sex & Gender Working Group
批准号:
10615834
负责人:
CHERYL M CAMERON
金额:
$6.19万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-04-01 至 2027-04-30
关键词:
AIDS preventionAcquired Immunodeficiency SyndromeAddressAnti-Retroviral AgentsAreaAttentionAwardAwarenessBasic ScienceBehaviorBehavioralBehavioral SciencesBiologicalBiologyCaringCell modelCellular biologyClinicalClinical ManagementClinical ResearchClinical SciencesCollaborationsCommunitiesContraceptive UsageCoupledCross-Sectional StudiesDevelopmentDiseaseDisease ProgressionDisparityEnrollmentEpidemicFeminizationFosteringFunding OpportunitiesGenderGoalsGonadal Steroid HormonesHIVHIV InfectionsHIV-1HormonalHormonesImmune responseImmunityImmunologyImmunotherapyIn VitroInequityInfectionInfrastructureInstitutionInterdisciplinary StudyInvestigationKnowledgeLeadershipLongitudinal cohortMenopausal StatusMenstrual cycleMentorsMentorshipMethodologyMolecularMolecular BiologyObesityOutcomePathogenesisPerformancePersonsPharmaceutical PreparationsPhasePopulationPredispositionPrevalencePreventionPsychologyPublic HealthReportingResearchResearch InfrastructureResearch PersonnelResourcesRiskRoleSamplingScientific InquirySex DifferencesSiteSociologyStructureTechniquesUniversitiesViolenceViralViral PathogenesisVirusWorkcis-femaledemographicsgender differencegender disparityimmune activationimprovedinnovationinsightlensmeetingsmembermultidisciplinaryprogramsrepositoryresponsesexsex disparitysocialsocioeconomicssuccesssynergismtransgendertransgender womentreatment responseworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT: SEX & GENDER SCIENTIFIC WORKING GROUP 1
There are notable sex- and gender-specific differences in the manifestations of both treated and untreated HIV-1
infection, but it remains to be unequivocally determined whether these are due to intrinsic differences in
immunological responses, differential susceptibility to the virus, behavioral modulators, effects due to hormonal
differences, or a combination of all these factors. Moreover, although more than 50% of people with HIV are either
cis- or transgender women, their under-enrollment in clinical studies has greatly limited our understanding of sex
and gender differences in HIV acquisition, mechanisms of immunity and latency, responses to antiretroviral drugs,
and behavioral tendencies, such as those driven by the socioeconomic challenges of gender inequity and risk of
violence. Addressing these crucial knowledge gaps on sex and gender differences in HIV will facilitate the
development of targeted strategies for HIV prevention, treatment, and cure, which are imperative to the goal of
globally eradicating HIV infection. The merger of the HIV research communities at CWRU and Pitt in the current
application to form the RUSTBELT CFAR has enabled the Sex & Gender SWG1 to assemble an exceptional
multidisciplinary team of basic, clinical, translational, and behavioral investigators, each of whom has conducted
at least one study on the role of gender or sex in HIV infection or treatment, or have expertise related to the
transgender community. Building on the unique strengths of each institution, the Sex & Gender SWG1 will work
closely with the RUSTBELT CFAR Cores to achieve the following Specific Aims: (1) To engage CFAR members
in research involving sex and gender differences in HIV pathogenesis. (2) To facilitate incorporation of sex and
gender differences in treatment, prevention, and cure-related HIV research. (3) To strategically coordinate a
formal mentorship program to make junior investigators aware of resources to study Sex & Gender. The success
of the Sex & Gender SWG1 will be evaluated based on a well-defined set of key performance metrics. Thus, by
taking advantage of the strong HIV prevention, pathogenesis, and cure research that is ongoing within the
RUSTBELT CFAR and combining it with our experts in behavioral sciences and public health, the Sex & Gender
SWG1 is ideally placed to provide unique insights into the control and management of the national and global
HIV epidemics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Using Systems Immunology to Get at the Nature of Mood Disorders in HIV
-
批准号:10369861
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2021
-
负责人:CHERYL M CAMERON
-
依托单位:
SWG1: Sex & Gender Working Group
-
批准号:10457728
-
项目类别:
-
资助金额:$4.01万
-
财政年份:1997
-
负责人:CHERYL M CAMERON
-
依托单位:
海外基金